Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 609

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 609
---
 a group of comparable publicly
traded biotechnology companies over a period equal to the expected term of the stock option grants. The comparable companies were chosen based on their similar industry, size, or stage in the product development life cycle and financial leverage.

Risk-Free Interest Rate– The risk-free interest rate is based on the U.S. Treasury zero coupon issues in effect at the time
of grant for periods corresponding with the expected term of option.

Expected Dividend– Other than the Distribution, Kineta
has never paid dividends on its common stock and has no plans to pay dividends on its common stock. Therefore, Kineta uses an expected dividend yield of zero.

Stock-based compensation was $1.2 million for the year ended December 31, 2024 and $3.9 million for the year ended December 31, 2023. As of
December 31, 2024, we had $0.9 million of total unrecognized stock-based compensation related to stock options, which we expect to recognize over a weighted-average period of 1.6 years.

405

KINETA EXECUTIVE COMPENSATION This section provides information regarding the total compensation awarded to, earned by, or paid to during the years ended December 31, 2023 and 2024 to (1) each individual who served as Kineta’s principal executive officer, (2) Kineta’s two next most highly compensated executive officers who earned more than $100,000 during the fiscal year ended December 31, 2024 and were serving as executive officers as of such date, and (3) up to two individuals who would otherwise be included in (2) above but for the fact that such individual was not serving as Kineta’s executive officer as of December 31, 2024. Kineta refers to these individuals in this proxy statement as Kineta’s named executive officers. Kineta’s named executive officers for 2024 who appear in the Summary Compensation Table are:

| • |     | Shawn Iadonato, Ph.D., Chair of the Kineta Board of Directors; |

| • |     | Craig W. Philips, President; and |

| • |     | Keith A. Baker, Chief Financial Officer. |

To date, the compensation of Kineta’s named executive officers has consisted of a combination of base salary, bonuses and long-term incentive compensation in the form of stock options and RSUs. Kineta’s named executive officers, like all full-time employees, are eligible to participate in Kineta’s